HSF1 activates the FOXO3a–ΔNp63α–CDK4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth
暂无分享,去创建一个
Z. Xiao | M. Sherman | Yujun Zhang | Mengmeng Niu | Wenhua Zhang | Yong Yi | Juan Ao | J. Fei | Shuhong Yu | Yuemeng Wang | Qile Zhu | Shiya Guo | Shi-Yao Guo | Junjie Fei
[1] Yumei Fan,et al. Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy , 2021, Oxidative medicine and cellular longevity.
[2] Bao Lou,et al. Hif-1α/Hsf1/Hsp70 signaling pathway regulates redox homeostasis and apoptosis in large yellow croaker (Larimichthys crocea) under environmental hypoxia , 2021, Zoological research.
[3] S. Kannan,et al. Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab , 2020, British Journal of Cancer.
[4] C. Ottensmeier,et al. HNSCC: Tumour Antigens and Their Targeting by Immunotherapy , 2020, Cells.
[5] P. Donkor,et al. Survival rates of head and neck cancers in Ghana: a retrospective study at the Komfo Anokye Teaching Hospital , 2020, BMC Research Notes.
[6] Yumei Fan,et al. Emerging roles of HSF1 in cancer: Cellular and molecular episodes. , 2020, Biochimica et biophysica acta. Reviews on cancer.
[7] Z. Xiao,et al. Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation , 2020, Proceedings of the National Academy of Sciences.
[8] R. Fisher,et al. Head and Neck Squamous Cell Carcinoma , 2020, Definitions.
[9] G. Basso,et al. HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia , 2019, International journal of cancer.
[10] Hung-Ming Wang,et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study , 2019, The Lancet.
[11] C. Dai,et al. Heat Shock Factor 1 Is a Direct Antagonist of AMP-Activated Protein Kinase. , 2019, Molecular cell.
[12] M. Kadakia,et al. TIP60 up-regulates ΔNp63α to promote cellular proliferation , 2019, The Journal of Biological Chemistry.
[13] I. Amelio,et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges , 2019, Cell Death & Disease.
[14] Zengqiang Yuan,et al. Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress , 2019, Redox biology.
[15] Y. Seo,et al. Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics , 2018, Molecules.
[16] Z. Xiao,et al. ΔNp63α down-regulates c-Myc modulator MM1 via E3 ligase HERC3 in the regulation of cell senescence , 2018, Cell Death & Differentiation.
[17] T. Ma,et al. c-Myc regulates the CDK1/cyclin B1 dependent-G2/M cell cycle progression by histone H4 acetylation in Raji cells , 2018, International journal of molecular medicine.
[18] Z. Xiao,et al. A double dealing tale of p63: an oncogene or a tumor suppressor , 2017, Cellular and Molecular Life Sciences.
[19] K. Shirahige,et al. The HSF1–PARP13–PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis , 2017, Nature Communications.
[20] D. Calvisi,et al. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis , 2017, Oncotarget.
[21] S. Khariwala,et al. Tobacco-related carcinogenesis in head and neck cancer , 2017, Cancer and Metastasis Reviews.
[22] Ke Chen,et al. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1‐dependent pathway , 2017, Molecular oncology.
[23] F. Cui,et al. C‐Myc regulates radiation‐induced G2/M cell cycle arrest and cell death in human cervical cancer cells , 2017, The journal of obstetrics and gynaecology research.
[24] A. Dey,et al. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker , 2017, Clinical and Translational Oncology.
[25] S. Westerheide,et al. The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model , 2016, PloS one.
[26] J. Radford. Nivolumab for recurrent squamous-cell carcinoma of the head and neck , 2016, BDJ.
[27] H. Naito,et al. Heat stress‐induced phosphorylation of FoxO3a signalling in rat skeletal muscle , 2016, Acta physiologica.
[28] J. Ahn,et al. The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma , 2016, Oncotarget.
[29] R. Pearson,et al. Unexpected role of CDK4 in a G2/M checkpoint , 2015, Cell cycle.
[30] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[31] N. Marchenko,et al. A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress , 2014, Cell Death and Disease.
[32] Simion I. Chiosea,et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. , 2013, Cancer discovery.
[33] Jun Yao,et al. Heat Shock Factor 1 (HSF1) Controls Chemoresistance and Autophagy through Transcriptional Regulation of Autophagy-related Protein 7 (ATG7)* , 2013, The Journal of Biological Chemistry.
[34] Marc L. Mendillo,et al. HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers , 2012, Cell.
[35] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[36] C. Van Waes,et al. ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. , 2011, Cancer research.
[37] D. Han,et al. KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter* , 2010, The Journal of Biological Chemistry.
[38] D. Antonini,et al. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. , 2010, The Journal of investigative dermatology.
[39] M Tan,et al. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth , 2009, Oncogene.
[40] T. Watts,et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium , 2007, BDJ.
[41] S. Ferrari,et al. Identification of New p63 Targets in Human Keratinocytes , 2006, Cell cycle.
[42] Jason S. Carroll,et al. p63 regulates an adhesion programme and cell survival in epithelial cells , 2006, Nature Cell Biology.
[43] L. Ellisen,et al. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. , 2006, Cancer cell.
[44] R. Dickson,et al. c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells , 2003, British Journal of Cancer.
[45] J F Barrett,et al. Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] Sung-Min Park,et al. Functional HSF 1 Requires Aromatic-Participant Interactions in Protecting Mouse Embryonic Fibroblasts against Apoptosis Via G 2 Cell Cycle Arrest , 2022 .